- This event has passed.
Translational Oncology Program Meeting
March 10, 2022 @ 3:30 pm - 4:30 pm
Liquid biopsy prediction of severe toxicity from melanoma immunotherapy
Aadel Chaudhuri, MD PhD
Assistant Professor, Department of Radiation Oncology
Washington University in St. Louis
This meeting will be conducted in a hybrid format. You have the option to attend in person at the Cancer Center or via Zoom. Register below to indicate your preference and receive a Zoom link. After registering, you will receive a confirmation email with information about joining the meeting and adding it to your calendar.
Aadel Chaudhuri, MD, PhD, is a physician-scientist and Assistant Professor of Radiation Oncology, Genetics, and Computer Science and Engineering at the Washington University in St. Louis. He is also the ctDNA working group leader at the Washington University Siteman Cancer Center.
Chaudhuri has received multiple major research awards including the American Society of Clinical Oncology Young Investigator Award, the Radiological Society of North America Roentgen Research Award, the NCI K08 Career Development Award, the V Scholar Award, and the NIGMS R35 Maximizing Investigators’ Research Award. His laboratory focuses on the development and application of liquid biopsy technologies for cancer detection, response prediction, and toxicity prediction. He recently published a paper in Nature Medicine showing that T cell features measured in peripheral blood could be used to accurately predict risk for severe immunotherapy toxicity in melanoma patients.
The meeting agenda includes a presentation, programmatic announcements, and updates from Cancer Center program leaders.
This group meets on the second Thursday of every month from 3:30 p.m. – 4:30 p.m.